Weld Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Weld Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-27,334	Closed	-$325K	–	1068
2019 Q2	$325K	Buy	+27,334	New	+$329K	0.06%	522
2019 Q1	–	Sell	-31,877	Closed	-$553K	–	940
2018 Q4	$553K	Buy	+31,877	New	+$544K	0.12%	310

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Weld Capital Management's VIVO Position: Q3 2019 in Review

Weld Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2019, closing a stake of 27,334 shares — an estimated $325K sold.

Weld Capital Management first reported a position in VIVO in Q4 2018 and held it in 2 quarters. The position peaked at $553K in Q4 2018. 163 funds tracked by Wall St. Rank hold VIVO as of Q3 2019.

Weld Capital Management reported no remaining Meridian Bioscience Inc position as of Q3 2019 after selling out during the quarter.
Weld Capital Management sold 27,334 Meridian Bioscience Inc shares in Q3 2019, an estimated $325K.
Weld Capital Management first reported a position in Meridian Bioscience Inc in Q4 2018 and held it in 2 quarters.
Weld Capital Management's Meridian Bioscience Inc position peaked at $553K in Q4 2018.
163 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2019.

Based on Weld Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.